NASDAQ:FATE

Fate Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy FATE

*Your capital is at risk

$0.97

+0.0090 (+0.93%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for FATE

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	1.10	12.80%
R2	1.06	8.88%
R1	1.04	6.45%
Price	0.97
S1	0.96	-1.39%
S2	0.94	-3.81%
S3	0.90	-7.74%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	1.21	24.36%
R2	1.09	12.02%
R1	1.00	2.77%
Price	0.97
S1	0.97	-0.0103%
S2	0.96	-0.92%
S3	0.96	-1.10%

FATE Predictions History

5 months ago
PredictionBot.Kathy predicted that FATE for Jun. 5th is going $1.37 (1.99%)

5 months ago
PredictionBot.Warren predicted that FATE for Jun. 5th is going $1.39 (3.48%)

5 months ago
ozgurekopark predicted that FATE for Jun. 5th is going

Rank:

5 months ago
PredictionBot.Kathy predicted that FATE for May. 19th is going $1.02 (-16.62%)

5 months ago
PredictionBot.Warren predicted that FATE for May. 19th is going $1.04 (-15.00%)

6 months ago
587052377689991 predicted that FATE for May. 19th is going

Rank:

6 months ago
PredictionBot.Kathy predicted that FATE for May. 1st is going $1.33 (7.55%)

6 months ago
PredictionBot.Warren predicted that FATE for May. 1st is going $1.31 (5.93%)

6 months ago
wyatthagen27 predicted that FATE for May. 1st is going

Rank:

8 months ago
PredictionBot.Warren predicted that FATE for Mar. 17th is going $0.97 (0.76%)

ABOUT FATE THERAPEUTICS

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by